Discontinued — last reported Q3 '21
Idexx Laboratories Income taxes payable – long-term increased by 0.6% to $14.54M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 35.8%, from $22.66M to $14.54M. Over 5 years (FY 2020 to FY 2025), Income taxes payable – long-term shows a downward trend with a -24.9% CAGR.
An increase often reflects long-term tax deferrals or structural changes in tax liabilities, while a decrease suggests the settlement or reduction of long-term tax obligations.
This reflects income tax liabilities that are not expected to be settled within the next twelve months. It often arises...
Common in multinational corporations with complex global tax structures and long-term deferred tax assets or liabilities.
other_accrued_income_taxes_noncurrent| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $58.13M | $58.73M | $56.47M | $57.26M | $50.53M | $50.86M | $49.14M | $51.56M | $42.70M | $40.91M | $39.64M | $40.03M | $28.69M | $30.50M | $20.90M | $22.66M | $14.11M | $14.78M | $14.45M | $14.54M |
| QoQ Change | — | +1.0% | -3.9% | +1.4% | -11.8% | +0.6% | -3.4% | +4.9% | -17.2% | -4.2% | -3.1% | +1.0% | -28.3% | +6.3% | -31.5% | +8.4% | -37.7% | +4.7% | -2.2% | +0.6% |
| YoY Change | — | — | — | — | -13.1% | -13.4% | -13.0% | -10.0% | -15.5% | -19.6% | -19.3% | -22.4% | -32.8% | -25.4% | -47.3% | -43.4% | -50.8% | -51.5% | -30.8% | -35.8% |